Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit Beuselinck

Showing results (11-20 of 117) with videos related to

Pageof 12
Sort By:
Bone|September 8, 2025
Understanding the genetic basis of medication-related osteonecrosis of the jaw: A systematic reviewSonya Radi, Deborah Sarah Jans, Catalina Moreno-Rabié, et al.
Cancer Investigation|April 8, 2011
Long-term response and postsurgical complete remissions after treatment with sunitinib malate, an oral multitargeted receptor tyrosine kinase inhibitor, in patients with metastatic renal cell carcinomaJorge Ayllon, Benoit Beuselinck, Alexandre Morel, et al.
The American Journal of Case Reports|April 10, 2013
Complete remission of pulmonary metastases of Bellini duct carcinoma with cisplatin, gemcitabine and bevacizumabEduardo Barrascout, Benoit Beuselinck, Jorge Ayllon, et al.
Bone|March 1, 2023
Risk of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents - A retrospective study of 240 patientsRuxandra Coropciuc, Renaat Coopman, Melisa Garip, et al.
Case Reports in Oncology|April 30, 2013
The use of high dosages of transdermal buprenorphine for pain management in palliative cancer patients: a case studyPaul M J Clement, Benoit Beuselinck, Karen Van Beek, et al.
Rheumatology International|April 30, 2025
Anti-TIF1-beta autoantibody-positive dermatomyositis: a case-based reviewJean-Baptiste Vulsteke, Petra De Haes, Minoru Satoh, et al.
Scandinavian Journal of Urology|September 14, 2020
Too good for CARMENA: criteria associated with long systemic therapy free intervals post cytoreductive nephrectomy for metastatic clear cell renal cell carcinomaEduard Roussel, Annelies Verbiest, Uros Milenkovic, et al.
European Radiology|August 29, 2014
Incidence of bowel wall oedema on computed tomography exams and association with diarrhoea in renal cell carcinoma patients treated with sunitinibLiesbeth Cornelissen, Filip Claus, Pascal Wolter, et al.
Urologic Oncology|January 24, 2021
C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumabEduard Roussel, Lisa Kinget, Annelies Verbiest, et al.
Acta Clinica Belgica|December 1, 2018
Bone metastases and age are associated with earlier dose reductions in metastatic clear-cell renal cell carcinoma patients treated with angiogenesis inhibitorsLorenz Haaker, Elisabeth De Meue, Hans Wildiers, et al.
Pageof 12

Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
Bone|September 8, 2025
Understanding the genetic basis of medication-related osteonecrosis of the jaw: A systematic reviewSonya Radi, Deborah Sarah Jans, Catalina Moreno-Rabié, et al.
Cancer Investigation|April 8, 2011
Long-term response and postsurgical complete remissions after treatment with sunitinib malate, an oral multitargeted receptor tyrosine kinase inhibitor, in patients with metastatic renal cell carcinomaJorge Ayllon, Benoit Beuselinck, Alexandre Morel, et al.
The American Journal of Case Reports|April 10, 2013
Complete remission of pulmonary metastases of Bellini duct carcinoma with cisplatin, gemcitabine and bevacizumabEduardo Barrascout, Benoit Beuselinck, Jorge Ayllon, et al.
Bone|March 1, 2023
Risk of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents - A retrospective study of 240 patientsRuxandra Coropciuc, Renaat Coopman, Melisa Garip, et al.
Case Reports in Oncology|April 30, 2013
The use of high dosages of transdermal buprenorphine for pain management in palliative cancer patients: a case studyPaul M J Clement, Benoit Beuselinck, Karen Van Beek, et al.
Rheumatology International|April 30, 2025
Anti-TIF1-beta autoantibody-positive dermatomyositis: a case-based reviewJean-Baptiste Vulsteke, Petra De Haes, Minoru Satoh, et al.
Scandinavian Journal of Urology|September 14, 2020
Too good for CARMENA: criteria associated with long systemic therapy free intervals post cytoreductive nephrectomy for metastatic clear cell renal cell carcinomaEduard Roussel, Annelies Verbiest, Uros Milenkovic, et al.
European Radiology|August 29, 2014
Incidence of bowel wall oedema on computed tomography exams and association with diarrhoea in renal cell carcinoma patients treated with sunitinibLiesbeth Cornelissen, Filip Claus, Pascal Wolter, et al.
Urologic Oncology|January 24, 2021
C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumabEduard Roussel, Lisa Kinget, Annelies Verbiest, et al.
Acta Clinica Belgica|December 1, 2018
Bone metastases and age are associated with earlier dose reductions in metastatic clear-cell renal cell carcinoma patients treated with angiogenesis inhibitorsLorenz Haaker, Elisabeth De Meue, Hans Wildiers, et al.
Pageof 12